Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 695

1.

Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia.

Finch ER, Smith CA, Yang W, Liu Y, Kornegay NM, Panetta JC, Crews KR, Molinelli AR, Cheng C, Pei D, Ramsey LB, Karol SE, Inaba H, Sandlund JT, Metzger M, Evans WE, Jeha S, Pui CH, Relling MV.

Pediatr Blood Cancer. 2019 Oct 14:e28040. doi: 10.1002/pbc.28040. [Epub ahead of print]

PMID:
31612640
2.

Association of school hours with outcomes of out-of-hospital cardiac arrest in schoolchildren.

Yamashita A, Kurosaki H, Takada K, Tanaka Y, Hamada Y, Ishita T, Kubo M, Inaba H.

Heart Asia. 2019 Aug 19;11(2):e011236. doi: 10.1136/heartasia-2019-011236. eCollection 2019.

3.

Mathematical analysis for an age-structured SIRS epidemic model.

Okuwa K, Inaba H, Kuniya T.

Math Biosci Eng. 2019 Jul 2;16(5):6071-6102. doi: 10.3934/mbe.2019304.

4.

Comparative analysis of human leucocyte antigen between idiopathic and anti-PD-1 antibody induced isolated adrenocorticotropic hormone deficiency: A pilot study.

Inaba H, Ariyasu H, Iwakura H, Ueda Y, Kurimoto C, Uraki S, Takeshima K, Yamaoka H, Furukawa Y, Morita S, Nishi M, Akamizu T.

Clin Endocrinol (Oxf). 2019 Aug 29. doi: 10.1111/cen.14082. [Epub ahead of print]

PMID:
31468541
5.

Fluorescent Tau-derived Peptide for Monitoring Microtubules in Living Cells.

Inaba H, Yamamoto T, Iwasaki T, Kabir AMR, Kakugo A, Sada K, Matsuura K.

ACS Omega. 2019 Jun 27;4(6):11245-11250. doi: 10.1021/acsomega.9b01089. eCollection 2019 Jun 30.

6.

Sorafenib population pharmacokinetics and skin toxicities in children and adolescents with refractory/relapsed leukemia or solid tumor malignancies.

Inaba H, Panetta JC, Pounds S, Wang L, Li L, Navid F, Federico SM, Eisenmann ED, Vasilyeva A, Wang YD, Shurtleff S, Pui CH, Gruber TA, Ribeiro RC, Rubnitz J, Baker SD.

Clin Cancer Res. 2019 Aug 27. pii: clincanres.0470.2019. doi: 10.1158/1078-0432.CCR-19-0470. [Epub ahead of print]

PMID:
31455680
7.
8.

Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor.

Pui CH, Pei D, Cheng C, Tomchuck SL, Evans SN, Inaba H, Jeha S, Raimondi SC, Choi JK, Thomas PG, Dallas MH.

Oncoimmunology. 2019 May 17;8(8):1599637. doi: 10.1080/2162402X.2019.1599637. eCollection 2019.

PMID:
31413907
9.

Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia.

Janke LJ, Van Driest SL, Portera MV, Atreya RV, Denny JC, Pei D, Cheng C, Kaste SC, Inaba H, Jeha S, Pui CH, Relling MV, Karol SE.

Blood. 2019 Sep 19;134(12):983-986. doi: 10.1182/blood.2019000006. Epub 2019 Aug 13. No abstract available.

PMID:
31409674
10.

Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AML.

Buelow DR, Pounds SB, Wang YD, Shi L, Li Y, Finkelstein D, Shurtleff S, Neale G, Inaba H, Ribeiro RC, Palumbo R, Garrison D, Orwick SJ, Blachly JS, Kroll K, Byrd JC, Gruber TA, Rubnitz JE, Baker SD.

Clin Transl Sci. 2019 Jul 26. doi: 10.1111/cts.12669. [Epub ahead of print]

PMID:
31350825
11.

Stabilization of microtubules by encapsulation of the GFP using a Tau-derived peptide.

Inaba H, Yamamoto T, Iwasaki T, Kabir AMR, Kakugo A, Sada K, Matsuura K.

Chem Commun (Camb). 2019 Aug 11;55(62):9072-9075. doi: 10.1039/c9cc04345d. Epub 2019 Jul 3.

PMID:
31268098
12.

Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial.

Rubnitz JE, Lacayo NJ, Inaba H, Heym K, Ribeiro RC, Taub J, McNeer J, Degar B, Schiff D, Yeoh AE, Coustan-Smith E, Wang L, Triplett B, Raimondi SC, Klco J, Choi J, Pounds S, Pui CH.

J Clin Oncol. 2019 Aug 10;37(23):2072-2081. doi: 10.1200/JCO.19.00327. Epub 2019 Jun 27.

PMID:
31246522
13.

Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine Society.

Arima H, Iwama S, Inaba H, Ariyasu H, Makita N, Otsuki M, Kageyama K, Imagawa A, Akamizu T.

Endocr J. 2019 Jul 28;66(7):581-586. doi: 10.1507/endocrj.EJ19-0163. Epub 2019 Jun 25.

14.

Association Between Anesthesia Exposure and Neurocognitive and Neuroimaging Outcomes in Long-term Survivors of Childhood Acute Lymphoblastic Leukemia.

Banerjee P, Rossi MG, Anghelescu DL, Liu W, Breazeale AM, Reddick WE, Glass JO, Phillips NS, Jacola LM, Sabin ND, Inaba H, Srivastava D, Robison LL, Pui CH, Hudson MM, Krull KR.

JAMA Oncol. 2019 Jun 20. doi: 10.1001/jamaoncol.2019.1094. [Epub ahead of print]

PMID:
31219514
15.

Antibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge.

Liu Y, Smith CA, Panetta JC, Yang W, Thompson LE, Counts JP, Molinelli AR, Pei D, Kornegay NM, Crews KR, Swanson H, Cheng C, Karol SE, Evans WE, Inaba H, Pui CH, Jeha S, Relling MV.

J Clin Oncol. 2019 Aug 10;37(23):2051-2061. doi: 10.1200/JCO.18.02439. Epub 2019 Jun 12.

PMID:
31188727
16.

Neonatal exposure to an inflammatory cytokine, epidermal growth factor, results in the deficits of mismatch negativity in rats.

Jodo E, Inaba H, Narihara I, Sotoyama H, Kitayama E, Yabe H, Namba H, Eifuku S, Nawa H.

Sci Rep. 2019 May 16;9(1):7503. doi: 10.1038/s41598-019-43923-y.

17.

A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML.

Drenberg CD, Shelat A, Dang J, Cotton A, Orwick SJ, Li M, Jeon JY, Fu Q, Buelow DR, Pioso M, Hu S, Inaba H, Ribeiro RC, Rubnitz JE, Gruber TA, Guy RK, Baker SD.

Nat Commun. 2019 May 16;10(1):2189. doi: 10.1038/s41467-019-09917-0.

18.

The basic reproduction number [Formula: see text] in time-heterogeneous environments.

Inaba H.

J Math Biol. 2019 Jul;79(2):731-764. doi: 10.1007/s00285-019-01375-y. Epub 2019 May 13.

PMID:
31087145
19.

Red Cell Distribution Width Predicts Prostate-Specific Antigen Response and Survival of Patients With Castration-Resistant Prostate Cancer Treated With Androgen Receptor Axis-Targeted Agents.

Fukuokaya W, Kimura T, Onuma H, Mori K, Honda M, Inaba H, Sasaki H, Shimomura T, Miki K, Egawa S.

Clin Genitourin Cancer. 2019 Jun;17(3):223-230. doi: 10.1016/j.clgc.2019.04.010. Epub 2019 Apr 16.

PMID:
31080022
20.

[Exhaustive analysis of genetic mutations associated with protein S deficiency utilizing next-generation sequencing analysis].

Ichiki A, Inaba H, Shinozawa K, Amano K, Fukutake K.

Rinsho Ketsueki. 2019;60(3):171-183. doi: 10.11406/rinketsu.60.171. Japanese.

PMID:
31068512

Supplemental Content

Loading ...
Support Center